vs
MGP INGREDIENTS INC（MGPI）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是MGP INGREDIENTS INC的1.6倍（$219.9M vs $138.3M），Orthofix Medical Inc.净利率更高（-1.0% vs -97.3%，领先96.3%），Orthofix Medical Inc.同比增速更快（2.0% vs -23.5%），MGP INGREDIENTS INC自由现金流更多（$24.3M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -9.9%）
MGP配料公司是总部位于美国的优质蒸馏酒、特种小麦和玉米基淀粉及蛋白质配料供应商，服务食品饮料制造、餐饮及工业客户领域，为北美及部分全球市场客户提供定制化配料解决方案。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MGPI vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.6倍
$138.3M
营收增速更快
OFIX
高出25.5%
-23.5%
净利率更高
OFIX
高出96.3%
-97.3%
自由现金流更多
MGPI
多$7.4M
$16.8M
两年增速更快
OFIX
近两年复合增速
-9.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $138.3M | $219.9M |
| 净利润 | $-134.6M | $-2.2M |
| 毛利率 | 34.9% | 71.1% |
| 营业利润率 | -97.7% | 0.2% |
| 净利率 | -97.3% | -1.0% |
| 营收同比 | -23.5% | 2.0% |
| 净利润同比 | -220.8% | 92.4% |
| 每股收益（稀释后） | $-6.23 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MGPIOFIX
| Q4 25 | $138.3M | $219.9M | ||
| Q3 25 | $130.9M | $205.6M | ||
| Q2 25 | $145.5M | $203.1M | ||
| Q1 25 | $121.7M | $193.6M | ||
| Q4 24 | $180.8M | $215.7M | ||
| Q3 24 | $161.5M | $196.6M | ||
| Q2 24 | $190.8M | $198.6M | ||
| Q1 24 | $170.6M | $188.6M |
净利润MGPIOFIX
| Q4 25 | $-134.6M | $-2.2M | ||
| Q3 25 | $15.4M | $-22.8M | ||
| Q2 25 | $14.4M | $-14.1M | ||
| Q1 25 | $-3.0M | $-53.1M | ||
| Q4 24 | $-42.0M | $-29.1M | ||
| Q3 24 | $23.9M | $-27.4M | ||
| Q2 24 | $32.1M | $-33.4M | ||
| Q1 24 | $20.6M | $-36.0M |
毛利率MGPIOFIX
| Q4 25 | 34.9% | 71.1% | ||
| Q3 25 | 37.8% | 72.2% | ||
| Q2 25 | 40.1% | 68.7% | ||
| Q1 25 | 35.6% | 62.8% | ||
| Q4 24 | 41.2% | 69.0% | ||
| Q3 24 | 40.8% | 68.7% | ||
| Q2 24 | 43.6% | 67.8% | ||
| Q1 24 | 36.8% | 67.5% |
营业利润率MGPIOFIX
| Q4 25 | -97.7% | 0.2% | ||
| Q3 25 | 16.1% | -8.3% | ||
| Q2 25 | 14.0% | -7.9% | ||
| Q1 25 | -0.6% | -25.2% | ||
| Q4 24 | -16.8% | -5.3% | ||
| Q3 24 | 20.2% | -9.6% | ||
| Q2 24 | 22.7% | -12.5% | ||
| Q1 24 | 17.0% | -15.6% |
净利率MGPIOFIX
| Q4 25 | -97.3% | -1.0% | ||
| Q3 25 | 11.8% | -11.1% | ||
| Q2 25 | 9.9% | -6.9% | ||
| Q1 25 | -2.5% | -27.4% | ||
| Q4 24 | -23.2% | -13.5% | ||
| Q3 24 | 14.8% | -13.9% | ||
| Q2 24 | 16.8% | -16.8% | ||
| Q1 24 | 12.1% | -19.1% |
每股收益（稀释后）MGPIOFIX
| Q4 25 | $-6.23 | $-0.05 | ||
| Q3 25 | $0.71 | $-0.57 | ||
| Q2 25 | $0.67 | $-0.36 | ||
| Q1 25 | $-0.14 | $-1.35 | ||
| Q4 24 | $-1.86 | $-0.76 | ||
| Q3 24 | $1.07 | $-0.71 | ||
| Q2 24 | $1.43 | $-0.88 | ||
| Q1 24 | $0.92 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.5M | $82.0M |
| 总债务越低越好 | $245.9M | — |
| 股东权益账面价值 | $718.4M | $450.0M |
| 总资产 | $1.2B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资MGPIOFIX
| Q4 25 | $18.5M | $82.0M | ||
| Q3 25 | $13.4M | $62.9M | ||
| Q2 25 | $17.3M | $65.6M | ||
| Q1 25 | $20.1M | $58.0M | ||
| Q4 24 | $25.3M | $83.2M | ||
| Q3 24 | $20.8M | $30.1M | ||
| Q2 24 | $21.0M | $26.4M | ||
| Q1 24 | $19.5M | $27.0M |
总债务MGPIOFIX
| Q4 25 | $245.9M | — | ||
| Q3 25 | $262.3M | $157.2M | ||
| Q2 25 | $290.7M | $157.0M | ||
| Q1 25 | $290.7M | $156.9M | ||
| Q4 24 | $317.1M | $157.0M | ||
| Q3 24 | $283.6M | $118.5M | ||
| Q2 24 | $303.0M | $118.0M | ||
| Q1 24 | $294.4M | $118.2M |
股东权益MGPIOFIX
| Q4 25 | $718.4M | $450.0M | ||
| Q3 25 | $855.2M | $442.5M | ||
| Q2 25 | $841.8M | $458.3M | ||
| Q1 25 | $828.3M | $458.3M | ||
| Q4 24 | $834.2M | $503.1M | ||
| Q3 24 | $914.5M | $525.9M | ||
| Q2 24 | $894.5M | $546.0M | ||
| Q1 24 | $867.0M | $570.3M |
总资产MGPIOFIX
| Q4 25 | $1.2B | $850.6M | ||
| Q3 25 | $1.4B | $832.6M | ||
| Q2 25 | $1.4B | $837.2M | ||
| Q1 25 | $1.4B | $823.1M | ||
| Q4 24 | $1.4B | $893.3M | ||
| Q3 24 | $1.4B | $867.9M | ||
| Q2 24 | $1.4B | $882.0M | ||
| Q1 24 | $1.4B | $906.0M |
负债/权益比MGPIOFIX
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.31× | 0.36× | ||
| Q2 25 | 0.35× | 0.34× | ||
| Q1 25 | 0.35× | 0.34× | ||
| Q4 24 | 0.38× | 0.31× | ||
| Q3 24 | 0.31× | 0.23× | ||
| Q2 24 | 0.34× | 0.22× | ||
| Q1 24 | 0.34× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $24.3M | $16.8M |
| 自由现金流率自由现金流/营收 | 17.5% | 7.6% |
| 资本支出强度资本支出/营收 | 3.5% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $76.0M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流MGPIOFIX
| Q4 25 | $29.1M | $27.7M | ||
| Q3 25 | $36.1M | $12.4M | ||
| Q2 25 | $11.7M | $11.6M | ||
| Q1 25 | $44.7M | $-18.4M | ||
| Q4 24 | $28.8M | $23.7M | ||
| Q3 24 | $43.9M | $11.7M | ||
| Q2 24 | $5.0M | $9.0M | ||
| Q1 24 | $24.6M | $-18.6M |
自由现金流MGPIOFIX
| Q4 25 | $24.3M | $16.8M | ||
| Q3 25 | $27.6M | $2.5M | ||
| Q2 25 | $-557.0K | $4.5M | ||
| Q1 25 | $24.8M | $-25.1M | ||
| Q4 24 | $10.4M | $15.2M | ||
| Q3 24 | $24.5M | $6.3M | ||
| Q2 24 | $-1.4M | $-360.0K | ||
| Q1 24 | $-2.4M | $-29.1M |
自由现金流率MGPIOFIX
| Q4 25 | 17.5% | 7.6% | ||
| Q3 25 | 21.1% | 1.2% | ||
| Q2 25 | -0.4% | 2.2% | ||
| Q1 25 | 20.4% | -13.0% | ||
| Q4 24 | 5.8% | 7.0% | ||
| Q3 24 | 15.2% | 3.2% | ||
| Q2 24 | -0.7% | -0.2% | ||
| Q1 24 | -1.4% | -15.4% |
资本支出强度MGPIOFIX
| Q4 25 | 3.5% | 4.9% | ||
| Q3 25 | 6.5% | 4.8% | ||
| Q2 25 | 8.4% | 3.5% | ||
| Q1 25 | 16.4% | 3.5% | ||
| Q4 24 | 10.1% | 4.0% | ||
| Q3 24 | 12.0% | 2.7% | ||
| Q2 24 | 3.3% | 4.7% | ||
| Q1 24 | 15.8% | 5.6% |
现金转化率MGPIOFIX
| Q4 25 | — | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.84× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 1.19× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGPI
| Branded Spirits | $63.4M | 46% |
| Ingredient Solutions | $31.3M | 23% |
| Specialty Wheat Starches | $16.8M | 12% |
| Mid Spirits | $16.1M | 12% |
| Other Branded Spirits | $8.0M | 6% |
| Commodity Wheat Starch | $2.3M | 2% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
